• Return to Headlines

Uptrend Call Working As Amicus Therapeut Stock Rises 97.8% (FOLD)

By Nick Russo

SmarTrend identified an Uptrend for Amicus Therapeut (NASDAQ:FOLD) on January 13th, 2017 at $5.89. In approximately 7 months, Amicus Therapeut has returned 97.79% as of today's recent price of $11.65.

In the past 52 weeks, Amicus Therapeut share prices have been bracketed by a low of $4.41 and a high of $14.05 and are now at $11.65, 164% above that low price. Over the last five market days, the 200-day moving average (MA) has gone down 1.9% while the 50-day MA has remained constant.

Amicus Therapeutics, Inc. is a biopharmaceutical company that develops orally-administered, small molecule drugs to treat human genetic diseases. The drugs, called pharmacological chaperones, are being developed to treat Fabray, Gaucher, and Pompe disease.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Amicus Therapeut shares.

Log in and add Amicus Therapeut (FOLD) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights amicus therapeut

Ticker(s): FOLD